Search

everythinglearnresearchcommunity

for

Search:↓

A 66-year-old woman's thick scalp and hair loss were confirmed as lipedematous alopecia, a rare condition possibly influenced by genetics, with no effective treatment known.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Many research paper titles in dermatology journals lack scientific precision.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Early detection and infection prevention are crucial for improving survival in pediatric lupus patients with aplastic anemia.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

Autologous platelet concentrates can effectively treat oral lichen planus like topical steroids.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Biologics for severe asthma have known side effects, but some new risks need more study.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Apremilast shows promise for several skin conditions but needs more research.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Lower BDNF levels link to worse depression in alopecia areata patients.

A child with low platelets and anemia was later found to have lupus.

A child had a rare case of scarring hair loss with skin disease, which is hard to treat and stressful.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

A unique case showed a rare combination of two types of lichen planus on the face.

Minoxidil was more effective than laser therapy for hair loss, and the report also highlighted the need for more research on PRP for a different hair loss condition, the impact of social media on alopecia views, and a warning on turmeric causing nail discoloration.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.